Public Health Trace

Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,271

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,852

Class I recallsReasonable probability of serious health consequences

24,397

Class II recallsTemporary or medically reversible health consequences

2,897

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,085 recalls

Newest recallhttps://www.fsis.usda.gov/recalls-alerts/kayem-foods-inc--recalls-meat-and-poultry-products-due-possible-temperature-abusePublished October 17, 2026

Most affected stateHawaii 200 recalls mention this state

State: KS ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 18, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

FDA Recall OngoingHistorical recordClass II

Dabigatran Etexilate, 150mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-475-60

by Ascend Laboratories, LLC

Reason: CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit
Published: December 18, 2024
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Dabigatran Etexilate, 75 mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-474-60

by Ascend Laboratories, LLC

Reason: CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit
Published: December 18, 2024
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 112 mcg, packaged in a) 90-count bottles (NDC 0378-1811-77) and b) 1000-count bottles (NDC 0378-1811-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason: Superpotent Drug and Subpotent Drug: potency failures obtained
Published: December 18, 2024
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b) 1000-count bottles (NDC 0378-1809-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason: Superpotent Drug and Subpotent Drug: potency failures obtained
Published: December 18, 2024
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0378-1807-77) and b) 1000-count bottles (NDC 0378-1807-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason: Superpotent Drug and Subpotent Drug: potency failures obtained
Published: December 18, 2024
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 75 mcg, packaged in a) 90-count bottles (NDC 0378-1805-77) and b) 1000-count bottles (NDC 0378-1805-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason: Superpotent Drug and Subpotent Drug: potency failures obtained
Published: December 18, 2024
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0378-1803-77) and b) 1000-count bottles (NDC 0378-1803-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason: Superpotent Drug and Subpotent Drug: potency failures obtained
Published: December 18, 2024
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 25 mcg, packaged in a) 90-count bottles (NDC 0378-1800-77) and b) 1000-count bottles (NDC 0378-1800-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason: Superpotent Drug and Subpotent Drug: potency failures obtained
Published: December 18, 2024
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 200 mcg, packaged in a) 90-count bottles (NDC 0378-1819-77) and b) 1000-count bottles (NDC 0378-1819-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason: Superpotent Drug and Subpotent Drug: potency failures obtained
Published: December 18, 2024
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC 0378-1817-77) and b) 1000-count bottles (NDC 0378-1817-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason: Superpotent Drug and Subpotent Drug: potency failures obtained
Published: December 18, 2024
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 150 mcg, packaged in a) 90-count bottles (NDC 0378-1815-77) and b) 1000-count bottles (NDC 0378-1815-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason: Superpotent Drug and Subpotent Drug: potency failures obtained
Published: December 18, 2024
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 137 mcg, packaged in a) 90-count bottles (NDC 0378-1823-77) and b) 1000-count bottles (NDC 0378-1823-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason: Superpotent Drug and Subpotent Drug: potency failures obtained
Published: December 18, 2024
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 125 mcg, packaged in a) 90-count bottles (NDC 0378-1813-77) and b) 1000-count bottles (NDC 0378-1813-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason: Superpotent Drug and Subpotent Drug: potency failures obtained
Published: December 18, 2024
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass III

Javygtor (sapropterin dihydrochloride) Tablets 100mg, 120-count bottle, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 Made in India, NDC 43598-096-04.

by Dr. Reddy's Laboratories, Inc.

Reason: Failed Impurities/Degradation Specifications
Published: December 18, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 2, 2025Historical recordClass II

Kirkland Severe Cold & Flu Plus Congestion: Day - 112 coated caplets blister pack; (Acetaminophen 325mg, Dextromethorphan HBr 10 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg); Night - 56 coated caplets blister pack; (Acetaminophen 325mg, Dextromethorphan HBr 10 mg, Doxylamine succinate 6.25 mg, Phenylephrine HCl 5 mg); Manufactured BY: LNK International, Inc. FOR: Costco Wholesale Corporation. NDC# 63981-795-81

by LNK International, Inc.

Reason: CGMP Deviations: Released product should have been rejected.
Published: December 18, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 21, 2025Historical recordClass III

Varithena (polidocanol injectable foam) Administration Pack, Contains: 3 silicone-free syringes, 2 compression pads, 1 Varithena Transfer Unit, 1 manometer tubing, Rx Only, Distributed by Biocompatibles Inc., a BTG International Group company. CN01114.3

by Biocompatibles UK, Ltd.

Reason: Defective Delivery System: incorrect silicone oil-free NormJect 10 mL Luer Lock Solo syringes packaged in the pack, instead of the required silicone oil-free NormJect 10 mL Luer Solo syringes (luer slip connection).
Published: December 18, 2024
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: January 10, 2025Historical recordClass II

Kim-Seng Company

Product: "***SUPER***BRAND***DRIED CINNAMON POWDER***Net Wt: 4oz(113g…
Reason: Elevated lead > 2ppm
Published: December 18, 2024
Distribution: Multiple states

View recall →

FDA Recall United States OngoingHistorical recordClass II

Tipp Distributors, Inc. dba Novamex

Product: Jarritos Coconut Water 17.5 fl oz cans- 12 cans per carton
Reason: The hermetic seal on the lid of the cans may be compromised
Published: December 18, 2024
Distribution: Only in the US. States: AL, AR, DE, FL,…

View recall →

FDA Recall United States TerminatedTerminated: September 24, 2025Historical recordClass II

Deseret Biologicals Inc

Product: DesBio lunaSOMM Natural Sleep Support Dietary Supplement ca…
Reason: Product contains undeclared soy lecithin.
Published: December 18, 2024
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 27, 2025Historical recordClass II

Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC: 0527-4661-37

by Lannett Company Inc.

Reason: Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.
Published: December 11, 2024
Distribution: Nationwide

View recall →

Data last updated: October 18, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.